Kiniksa Pharmaceuticals International, plc (KNSA) insider trading

By person

20 insiders · 237 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Sanj K Patel

Chairman & CEO

—

$94.09M (54) scheduled

−$94.09M

1,969,594

$185.63M

+64.8%

Baker Bros. Advisors LP entity

Director

$54.00M (2)

—

+$54.00M

2,759,734

$260.10M

—

John F. Paolini

Chief Medical Officer

—

$22.98M (40) scheduled

−$22.98M

69,922

$6.59M

+5,641%

Eben Tessari

Chief Strategy Officer

—

$19.65M (34) scheduled

−$19.65M

23,130

$2.18M

−78.4%

James E Flynn

10% owner

$16.00M (4)

—

+$16.00M

843,352

$79.49M

—

Mark Ragosa

Chief Financial Officer

—

$15.85M (28) scheduled

−$15.85M

20,854

$1.97M

+190.5%

Ross Moat

Chief Operating Officer

—

$15.45M (22) scheduled

−$15.45M

10,294

$970.21K

+94.7%

Michael R Megna

Chief Accounting Officer

—

$9.12M (22) scheduled

−$9.12M

12,697

$1.20M

+702.1%

Thomas Malley

Director

—

$5.86M (3) scheduled

−$5.86M

87,312

$8.23M

—

Barry D Quart

Director

—

$3.87M (12) scheduled

−$3.87M

12,745

$1.20M

—

Thomas W. Beetham

EVP & Chief Legal Officer

—

$2.11M (8)

−$2.11M

297,523

$28.04M

+306.5%

Cormorant Asset Management, LP entity

10% owner

$1.25M (1)

—

+$1.25M

1,731,442

$163.19M

+108.4%

G Bradley Cole

Director

—

$299.09K (1)

−$299.09K

7,172

$675.96K

—

Stephen F. Mahoney

President & COO

—

79,589

$7.50M

+8.7%

Carsten Boess

10% owner

—

79,589

$7.50M

+8.7%

Chris Heberlig

EVP & CFO

—

42,991

$4.05M

+17.5%

Richard S Levy

Director

—

22,359

$2.11M

—

Kimberly J Popovits

Director

—

15,345

$1.45M

—

Tracey L McCain

Director

—

15,345

$1.45M

—

Qasim Rizvi

Chief Commercial Officer

—

5,176

$487.84K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Kiniksa Pharmaceuticals International, plc

What the insiders did Net buying

By person